The store will not work correctly when cookies are disabled.
3-Hydroxy-4-methoxy-N-(3,4,5-trimethoxy-phenyl)-benzamide
ID: ALA162908
PubChem CID: 25255225
Max Phase: Preclinical
Molecular Formula: C17H19NO6
Molecular Weight: 333.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)Nc2cc(OC)c(OC)c(OC)c2)cc1O
Standard InChI: InChI=1S/C17H19NO6/c1-21-13-6-5-10(7-12(13)19)17(20)18-11-8-14(22-2)16(24-4)15(9-11)23-3/h5-9,19H,1-4H3,(H,18,20)
Standard InChI Key: NMNNKCCUFCWESB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
7.9792 -3.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1167 -3.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -4.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1167 -3.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5500 -3.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2625 -2.6417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9792 -3.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -2.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5500 -3.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6917 -4.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7042 -5.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9875 -5.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6917 -2.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -4.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -5.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -4.3000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -5.1250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -2.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4167 -5.5125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9917 -6.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 -3.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1167 -5.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -1.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2792 -6.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 9 2 0
4 8 1 0
5 6 1 0
6 1 1 0
7 1 1 0
8 5 2 0
9 5 1 0
10 7 1 0
11 10 2 0
12 15 2 0
13 1 2 0
14 7 2 0
15 14 1 0
16 2 1 0
17 3 1 0
18 4 1 0
19 11 1 0
20 12 1 0
21 16 1 0
22 17 1 0
23 18 1 0
24 20 1 0
11 12 1 0
2 4 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.34 | Molecular Weight (Monoisotopic): 333.1212 | AlogP: 2.68 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.22 | CX Basic pKa: ┄ | CX LogP: 2.13 | CX LogD: 2.12 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -0.43 |
References
1. Shirai R, Tokuda K, Koiso Y, Iwasaki S. (1994) Synthesis and nti-tubulin activity of aza-combretastatins, 4 (5): [10.1016/S0960-894X(01)80183-9] |